JP2004504840A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004504840A5 JP2004504840A5 JP2002516291A JP2002516291A JP2004504840A5 JP 2004504840 A5 JP2004504840 A5 JP 2004504840A5 JP 2002516291 A JP2002516291 A JP 2002516291A JP 2002516291 A JP2002516291 A JP 2002516291A JP 2004504840 A5 JP2004504840 A5 JP 2004504840A5
- Authority
- JP
- Japan
- Prior art keywords
- fragment
- exon
- translation
- dna
- encoding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 description 31
- 239000012634 fragment Substances 0.000 description 30
- 238000000034 method Methods 0.000 description 28
- 108020004414 DNA Proteins 0.000 description 24
- 102000004169 proteins and genes Human genes 0.000 description 15
- 108020001580 protein domains Proteins 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 12
- 230000008685 targeting Effects 0.000 description 10
- 230000035897 transcription Effects 0.000 description 9
- 238000013518 transcription Methods 0.000 description 9
- 108091028043 Nucleic acid sequence Proteins 0.000 description 8
- 108020005067 RNA Splice Sites Proteins 0.000 description 8
- 108700024394 Exon Proteins 0.000 description 7
- 108020004705 Codon Proteins 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 4
- 230000006801 homologous recombination Effects 0.000 description 4
- 238000002744 homologous recombination Methods 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 108091036066 Three prime untranslated region Proteins 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000014621 translational initiation Effects 0.000 description 2
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 102400001047 Endostatin Human genes 0.000 description 1
- 108010079505 Endostatins Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101000852559 Homo sapiens Thioredoxin Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000007999 Nuclear Proteins Human genes 0.000 description 1
- 108010089610 Nuclear Proteins Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 102000014128 RANK Ligand Human genes 0.000 description 1
- 108010025832 RANK Ligand Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 102100036407 Thioredoxin Human genes 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001772 anti-angiogenic effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 108020004084 membrane receptors Proteins 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 108091005703 transmembrane proteins Proteins 0.000 description 1
- 102000035160 transmembrane proteins Human genes 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0018876.3A GB0018876D0 (en) | 2000-08-01 | 2000-08-01 | Method of producing polypeptides |
| GB0018876.3 | 2000-08-01 | ||
| PCT/GB2001/003455 WO2002010372A1 (en) | 2000-08-01 | 2001-08-01 | Method of producing functional protein domains |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004504840A JP2004504840A (ja) | 2004-02-19 |
| JP2004504840A5 true JP2004504840A5 (https=) | 2012-08-09 |
| JP5068916B2 JP5068916B2 (ja) | 2012-11-07 |
Family
ID=9896767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002516291A Expired - Fee Related JP5068916B2 (ja) | 2000-08-01 | 2001-08-01 | 機能タンパク質ドメインの産生方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8048645B2 (https=) |
| EP (1) | EP1305411B1 (https=) |
| JP (1) | JP5068916B2 (https=) |
| CN (1) | CN1468304B (https=) |
| AR (1) | AR031717A1 (https=) |
| AT (1) | ATE398174T1 (https=) |
| AU (1) | AU7573901A (https=) |
| BR (1) | BR0112979A (https=) |
| CA (1) | CA2415768C (https=) |
| CY (1) | CY1110431T1 (https=) |
| DE (1) | DE60134410D1 (https=) |
| DK (1) | DK1305411T3 (https=) |
| ES (1) | ES2305091T3 (https=) |
| GB (1) | GB0018876D0 (https=) |
| IL (1) | IL154212A0 (https=) |
| NO (1) | NO330897B1 (https=) |
| PT (1) | PT1305411E (https=) |
| SI (1) | SI1305411T1 (https=) |
| WO (1) | WO2002010372A1 (https=) |
| ZA (1) | ZA200300827B (https=) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE354645T1 (de) * | 2002-12-20 | 2007-03-15 | Chromagenics Bv | Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können |
| NZ544263A (en) * | 2003-06-10 | 2009-04-30 | Nsgene As | Improved secretion of neublastin |
| US8053191B2 (en) | 2006-08-31 | 2011-11-08 | Westend Asset Clearinghouse Company, Llc | Iterative nucleic acid assembly using activation of vector-encoded traits |
| WO2011053957A2 (en) * | 2009-11-02 | 2011-05-05 | Gen9, Inc. | Compositions and methods for the regulation of multiple genes of interest in a cell |
| WO2012064975A1 (en) | 2010-11-12 | 2012-05-18 | Gen9, Inc. | Protein arrays and methods of using and making the same |
| CN103502448B (zh) | 2010-11-12 | 2017-03-29 | Gen9股份有限公司 | 核酸合成的方法和设备 |
| LT2944693T (lt) | 2011-08-26 | 2019-08-26 | Gen9, Inc. | Kompozicijos ir būdai, skirti nukleorūgščių didelio tikslumo sąrankai |
| US9150853B2 (en) | 2012-03-21 | 2015-10-06 | Gen9, Inc. | Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis |
| CA2871505C (en) | 2012-04-24 | 2021-10-12 | Gen9, Inc. | Methods for sorting nucleic acids and multiplexed preparative in vitro cloning |
| IL236303B (en) | 2012-06-25 | 2022-07-01 | Gen9 Inc | Methods for high-throughput nucleic acid assembly and sequencing |
| SG11201600853UA (en) | 2013-08-05 | 2016-03-30 | Twist Bioscience Corp | De novo synthesized gene libraries |
| CA2975855C (en) | 2015-02-04 | 2025-09-23 | Twist Bioscience Corporation | SYNTHETIC GENE COMPOSITIONS AND ASSEMBLY METHODS |
| US10669304B2 (en) | 2015-02-04 | 2020-06-02 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
| US9981239B2 (en) | 2015-04-21 | 2018-05-29 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
| EP3350314A4 (en) | 2015-09-18 | 2019-02-06 | Twist Bioscience Corporation | OLIGONUCLEIC ACID VARIANT LIBRARIES VARIANT AND SYNTHESIS THEREOF |
| KR102794025B1 (ko) | 2015-09-22 | 2025-04-09 | 트위스트 바이오사이언스 코포레이션 | 핵산 합성을 위한 가요성 기판 |
| CN115920796A (zh) | 2015-12-01 | 2023-04-07 | 特韦斯特生物科学公司 | 功能化表面及其制备 |
| EP3500672A4 (en) | 2016-08-22 | 2020-05-20 | Twist Bioscience Corporation | DE NOVO SYNTHETIZED NUCLEIC ACID LIBRARIES |
| US10417457B2 (en) | 2016-09-21 | 2019-09-17 | Twist Bioscience Corporation | Nucleic acid based data storage |
| GB2573069A (en) | 2016-12-16 | 2019-10-23 | Twist Bioscience Corp | Variant libraries of the immunological synapse and synthesis thereof |
| EP4556433A3 (en) | 2017-02-22 | 2025-08-06 | Twist Bioscience Corporation | Nucleic acid based data storage |
| WO2018170169A1 (en) | 2017-03-15 | 2018-09-20 | Twist Bioscience Corporation | Variant libraries of the immunological synapse and synthesis thereof |
| WO2018231872A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
| WO2018231864A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
| US11407837B2 (en) | 2017-09-11 | 2022-08-09 | Twist Bioscience Corporation | GPCR binding proteins and synthesis thereof |
| CN111565834B (zh) | 2017-10-20 | 2022-08-26 | 特韦斯特生物科学公司 | 用于多核苷酸合成的加热的纳米孔 |
| KR102804057B1 (ko) | 2018-01-04 | 2025-05-07 | 트위스트 바이오사이언스 코포레이션 | Dna 기반 디지털 정보 저장 |
| CA3100739A1 (en) | 2018-05-18 | 2019-11-21 | Twist Bioscience Corporation | Polynucleotides, reagents, and methods for nucleic acid hybridization |
| WO2020139871A1 (en) | 2018-12-26 | 2020-07-02 | Twist Bioscience Corporation | Highly accurate de novo polynucleotide synthesis |
| CN113766930B (zh) | 2019-02-26 | 2025-07-22 | 特韦斯特生物科学公司 | Glp1受体的变异核酸文库 |
| JP2022522668A (ja) | 2019-02-26 | 2022-04-20 | ツイスト バイオサイエンス コーポレーション | 抗体を最適化するための変異体核酸ライブラリ |
| US11332738B2 (en) | 2019-06-21 | 2022-05-17 | Twist Bioscience Corporation | Barcode-based nucleic acid sequence assembly |
| EP4034566A4 (en) | 2019-09-23 | 2024-01-24 | Twist Bioscience Corporation | VARIANT NUCLEIC ACID BANKS FOR CRTH2 |
| JP2022548783A (ja) | 2019-09-23 | 2022-11-21 | ツイスト バイオサイエンス コーポレーション | 単一ドメイン抗体のバリアント核酸ライブラリー |
| BR112022011235A2 (pt) | 2019-12-09 | 2022-12-13 | Twist Bioscience Corp | Bibliotecas de variantes de ácido nucleico para receptores de adenosina |
| WO2022067214A2 (en) | 2020-09-28 | 2022-03-31 | Vestaron Corporation | Mu-diguetoxin-dc1a variant polypeptides for pest control |
| WO2022235929A1 (en) | 2021-05-05 | 2022-11-10 | Radius Pharmaceuticals, Inc. | Animal model having homologous recombination of mouse pth1 receptor |
| WO2023122805A1 (en) | 2021-12-20 | 2023-06-29 | Vestaron Corporation | Sorbitol driven selection pressure method |
| WO2024026406A2 (en) | 2022-07-29 | 2024-02-01 | Vestaron Corporation | Next Generation ACTX Peptides |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2646438B1 (fr) | 1989-03-20 | 2007-11-02 | Pasteur Institut | Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration |
| EP0945515A3 (en) | 1989-11-06 | 2002-08-21 | Cell Genesys, Inc. | Production of proteins using homologous recombination |
| ES2151463T5 (es) * | 1989-12-22 | 2012-10-29 | Merck Serono Sa | Constructos de ADN para la activación y la modificación de la expresión de genes endógenos |
| US5272071A (en) | 1989-12-22 | 1993-12-21 | Applied Research Systems Ars Holding N.V. | Method for the modification of the expression characteristics of an endogenous gene of a given cell line |
| WO1993004169A1 (en) * | 1991-08-20 | 1993-03-04 | Genpharm International, Inc. | Gene targeting in animal cells using isogenic dna constructs |
| US5733761A (en) | 1991-11-05 | 1998-03-31 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
| US6270989B1 (en) | 1991-11-05 | 2001-08-07 | Transkaryotic Therapies, Inc. | Protein production and delivery |
| US6063630A (en) * | 1991-11-05 | 2000-05-16 | Transkaryotic Therapies, Inc. | Targeted introduction of DNA into primary or secondary cells and their use for gene therapy |
| US5641670A (en) * | 1991-11-05 | 1997-06-24 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
| TW402639B (en) | 1992-12-03 | 2000-08-21 | Transkaryotic Therapies Inc | Protein production and protein delivery |
| CN1256986C (zh) * | 1993-12-02 | 2006-05-24 | 转移染色体治疗公司 | 蛋白质的生产和蛋白质的输送 |
| US5545817A (en) * | 1994-03-11 | 1996-08-13 | Calgene, Inc. | Enhanced expression in a plant plastid |
| US6229006B1 (en) | 1995-12-22 | 2001-05-08 | Smithkline Beecham Corporation | Use of antisense oligodeoxynucleotides to produce truncated proteins |
| IL135242A0 (en) * | 1997-09-26 | 2001-05-20 | Athersys Inc | Expression of endogenous genes by non-homologous recombination of a vector construct with cellular dna |
| US7063960B2 (en) * | 1997-12-12 | 2006-06-20 | The Rockefeller University | Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof |
| AU751520B2 (en) * | 1998-03-27 | 2002-08-15 | Lexicon Pharmaceuticals, Inc. | Vectors for gene mutagenesis and gene discovery |
| US6436707B1 (en) | 1998-03-27 | 2002-08-20 | Lexicon Genetics Incorporated | Vectors for gene mutagenesis and gene discovery |
| JP3688118B2 (ja) * | 1998-05-22 | 2005-08-24 | 独立行政法人科学技術振興機構 | 遺伝子トラップ用ベクターと、このベクターを用いた遺伝子トラップ方法 |
-
2000
- 2000-08-01 GB GBGB0018876.3A patent/GB0018876D0/en not_active Ceased
-
2001
- 2001-07-31 AR ARP010103647A patent/AR031717A1/es active IP Right Grant
- 2001-08-01 JP JP2002516291A patent/JP5068916B2/ja not_active Expired - Fee Related
- 2001-08-01 AT AT01953251T patent/ATE398174T1/de active
- 2001-08-01 CN CN01816657.1A patent/CN1468304B/zh not_active Expired - Fee Related
- 2001-08-01 IL IL15421201A patent/IL154212A0/xx unknown
- 2001-08-01 CA CA2415768A patent/CA2415768C/en not_active Expired - Fee Related
- 2001-08-01 US US10/343,684 patent/US8048645B2/en not_active Expired - Fee Related
- 2001-08-01 WO PCT/GB2001/003455 patent/WO2002010372A1/en not_active Ceased
- 2001-08-01 PT PT01953251T patent/PT1305411E/pt unknown
- 2001-08-01 ES ES01953251T patent/ES2305091T3/es not_active Expired - Lifetime
- 2001-08-01 SI SI200130842T patent/SI1305411T1/sl unknown
- 2001-08-01 DK DK01953251T patent/DK1305411T3/da active
- 2001-08-01 EP EP01953251A patent/EP1305411B1/en not_active Expired - Lifetime
- 2001-08-01 BR BR0112979-1A patent/BR0112979A/pt not_active Application Discontinuation
- 2001-08-01 AU AU7573901A patent/AU7573901A/xx not_active Withdrawn
- 2001-08-01 DE DE60134410T patent/DE60134410D1/de not_active Expired - Lifetime
-
2003
- 2003-01-28 NO NO20030443A patent/NO330897B1/no not_active IP Right Cessation
- 2003-01-30 ZA ZA200300827A patent/ZA200300827B/xx unknown
-
2008
- 2008-07-11 CY CY20081100728T patent/CY1110431T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004504840A5 (https=) | ||
| CA2415768A1 (en) | Method of producing functional protein domains | |
| JP2008528033A5 (https=) | ||
| KR20110062997A (ko) | 유비퀴틴 또는 유비퀴틴-유사 단백질, 막 투과 도메인 및 생물학적 활성분자를 포함하는 융합 단백질 및 그의 용도 | |
| JPH04501955A (ja) | 新規レセプター：それらの同定、特微付け、製造および使用 | |
| JPH0755151B2 (ja) | 選定蛋白質およびそれをコードする組替えｄｎａ分子 | |
| JP2007525207A5 (https=) | ||
| JP2003535564A5 (https=) | ||
| JPH07506090A (ja) | 組換え可溶性組織因子の発現および精製 | |
| JP2024542811A5 (https=) | ||
| US8304210B2 (en) | Method for the secretory production of heterologous protein in Escherichia coli | |
| JP2008509682A5 (https=) | ||
| CA2343839A1 (en) | Cytokine receptor zalpha11 | |
| CA2039153A1 (fr) | Lignees cellulaires exprimant un facteur ix biologiquement actif | |
| JP4870683B2 (ja) | オステオプロテゲリン・バリアントタンパク質 | |
| RU2009120298A (ru) | Набор последовательностей для таргетинга экспрессии и контроля посттрансляционных модификаций рекомбинантного полипептида | |
| CA2573022A1 (en) | Novel sequence for improving expression of nucleic acid | |
| WO2013013626A1 (zh) | 重组人神经生长因子缺失突变体及其制备方法和用途 | |
| JP2003514549A5 (https=) | ||
| CN104672333A (zh) | 一种人源ctla4融合蛋白及其制备方法和应用 | |
| JP3499528B2 (ja) | シグナルシーケンストラップ法 | |
| CN106929512A (zh) | St2抗原的制备及其专用编码dna分子 | |
| CN110229849B (zh) | 时空调控型uPA基因表达非病毒载体及其制备方法和应用 | |
| JPH04144684A (ja) | エンドセリン受容体 | |
| CN112501124A (zh) | 稳定表达人转铁蛋白受体1细胞株的制备方法及其应用 |